DHG keeps throne by continuous innovation to create new values

The co-operation with Taisho yielded strong results for DHG

In 2019, DHG returned with a full bag from the 2019 Listed Company Award with the award for corporate governance for enterprises with big capitalisation, the plaque for the top five enterprises having the best sustainable development strategy, and a spot among the top 10 enterprises with the best annual reports – all adding to the considerable success the company has achieved at previous iterations of the awards.

DHG’s consistent high ranking at the Listed Company Award demonstrates the company’s resilience to weather all challenges and remain the leading pharmaceutical firm in Vietnam, a task that requires the constant creation of new values and sustainable development. The company’s achievements are a result of the precise and consistent implementation of an overarching vision. DHG has embedded five core principles in its corporate governance, including ensuring a sound governance structure; ensuring the effective operation of the board of directors and the supervision board; ensuring the benefits of all stakeholders; ensuring equal treatment for all stakeholders; and ensuring transparency in all activities.

The company’s strength is found in its strong resources, including its major Japanese stakeholder Taisho continuing to increase equity and expanding supportive activities, especially in terms of market expansion. This has been highly appreciated by investors.

Specifically, Taisho’s help was essential in obtaining the internationally-recognised PIC/S GMP certificate for its production lines of effervescent powder and effervescent capsule and the Japan GMP certificate for the capsule production line – both of which are testament to DHG’s non-stop efforts to evolve through advanced technology and highly skilled employees. The company’s core values of ensuring “quality, safety, and effectiveness” to partners, customers, and consumers have been highlighted time and again, flagging DHG as the leading pharmaceutical producer in Vietnam. The company has also been touted as instrumental in raising up the pharmaceutical sector of the Mekong Delta city of Can Tho, where the company’s headquarters are located.

These big achievements earned DHG the vote of confidence from medical practitioners and hospitals who use its products, and laid down the foundations for the firm to expand to the global market and export products to Japan and all markets in Southeast Asia. Currently, DHG exports products to 14 countries.

The partnership with Taisho will help DHG take advantage of the Japanese company’s distribution network, and brings positive prospects of a much stronger export turnover in the years to come. In order to unfold the company’s international reach, hundreds of engineers, pharmacists, researchers, and experts from DHG have been sent to Japan for training. This will also improve the company’s internal strength to perform better at its existing markets, by providing the best conditions to all employees.

The partnership not only helps DHG and Taisho improve their competitiveness internationally, but also enables local consumers to enjoy locally-produced, international-standard pharmaceutical products at reasonable prices through DHG’s distribution network of over 28,000 outlets nationwide.